El desafío de las infecciones MDR y XDR 2026

Hospital Clínic de Barcelona.

Head of Section for immunosuppressed and severe bacteria at University Hospital Germans Trias i Pujol. Investigator Member of CIBERes and AGAUR.

Dr. Pedro-Botet is specialized in Infectious Diseases, Respiratory Infections and Legionella. She is currently Professor and Chair of Medicine and a member of the Grade of Medicine Committee at the Autonomous University of Barcelona’s School of Medicine. She has been Principal or co-Investigator of 10 projects funded either by national or international grant agencies. Author of 91 papers in peer-reviewed journals.

Roger Paredes, MD, PhD, is the Head of the Infectious Diseases Service at Hospital Universitari Germans Trias i Pujol, Head of the Microbial Genomics Group at the IrsiCaixa AIDS Research Institute, Badalona, Spain.

Roger Paredes obtained an MD, PhD degree in Medicine and Surgery from the Autonomous University of Barcelona (UAB). He specialised in HIV resistance at the Brigham & Women’s Hospital in Boston and Harvard Medical School. His team has demonstrated the clinical utility of HIV-1 deep sequencing in both high- and low-income countries.

Jesús Rodríguez Baño is a Professor in the Department of Medicine at the University of Seville, Head of the Infectious Diseases Department at the Virgen Macarena University Hospital in Seville, and Principal Investigator of the Clinical Research Group on Infectious Diseases at the Institute of Biomedicine of Seville. He is an Associate Editor of the journal Clinical Microbiology and Infection.

He has served as President of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), a member of the Scientific Committee of the Joint Programme Initiative on Antimicrobial Resistance (JPI-AMR) of the European Union, and is a consultant for the European Centre for Disease Control and Prevention (ECDC) on antimicrobial resistance.

His research focuses on the epidemiological and clinical aspects, as well as the treatment, of infections caused by resistant bacteria and the use of antimicrobials. He has been and continues to be the principal investigator of several national and European research projects, with 500 publications in scientific journals, a Web of Science H-index of 73, and recognition as a Highly Cited Researcher in 2023 and 2024.

Specialist in Infectious Diseases, Doctor in Medicine and Translational Research, expert in infections in oncohematologic patients and fungal infections.

Marta Hernández-Meneses is a specialist in Internal Medicine and Infectious Diseases. She completed her residency at Hospital Universitario Dr. Negrín (HUDNGC) and further specialized at Hospital Clínic de Barcelona, earning an International Ph.D. (UB, 2023). She holds three master’s degrees: HIV (UB, 2019), Applied Statistics in Health Sciences (UAB, 2019), and Infectious Diseases in Mobile Populations – International Health (UB, 2023). Her international training includes fellowships at Mayo Clinic (2019) and Brigham and Women’s Hospital – Harvard Medical School (2023), focusing on cardiovascular infections, mechanical circulatory support, cardiac and lung transplants, and ICU infections.
For the past eight years, she has been providing clinical care at the Infectious Diseases Department of Hospital Clínic de Barcelona focusing on critical care, cardiovascular infections, and infections in gynecology, obstetrics, and neonatology.
Her clinical and research work centers on cardiovascular infections, combining clinical studies with in vitro and in vivo models of biofilm and infective endocarditis. She has authored over 90 PubMed-indexed articles (H-index 23) and leads the PREDICT study on radiomics for diagnosing cardiovascular infections (AES-FIS 2024). Since 2020, she has been an associate professor at the University of Barcelona.

Inmaculada López Montesinos is Deputy of the Infectious Diseases Service at Hospital del Mar in Barcelona, a professor of medicine at Pompeu Fabra University, and holds a PhD in Medicine from the Autonomous University of Barcelona. She is a member of the CIBERINFEC network of the Carlos III Institute. Her main research focus is the study and treatment of infections caused by multidrug-resistant bacteria, with a particular interest in Pseudomonas aeruginosa.